0.4% Lidocaine Hydrochloride and 5% Dextrose Injection Shortage Reported
An active shortage has been reported for 0.4% Lidocaine Hydrochloride and 5% Dextrose Injection, according to the Drug Shortages Canada database.
What’s in Shortage
Drug Name: 0.4% Lidocaine Hydrochloride and 5% Dextrose Injection
Dosage Form: Injection
Current Status: Active
Which Manufacturers Are Affected
The official report (Shortage ID: 179915) does not currently list a specific manufacturer, brand name, or Drug Identification Number (DIN) associated with this shortage entry. Availability status for specific suppliers is not provided in the source data.
Why There’s a Shortage
No specific reason for this shortage was provided in the official report.
What Patients Should Do
If you or a family member rely on this medication, please take the following steps:
- Consult your healthcare provider: Discuss your treatment plan and any concerns regarding medication availability.
- Speak with your pharmacist: They can provide the most current information on local stock levels and potential next steps.
- Seek professional guidance: Do not attempt to use alternative medications or change your treatment without consulting a medical professional.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider regarding their specific medical needs and treatment options.
Source
Attribution: Drug Shortages Canada (Shortage ID: 179915).
Related Articles
0.9% Sodium Chloride Injection, USP Facing Active Shortage in Canada
Drug Shortages Canada · March 4, 2026
0.9% Sodium Chloride Injection Shortage Reported
Drug Shortages Canada · February 16, 2026
0.9% Sodium Chloride Injection Shortage: Current Status and Information
Drug Shortages Canada · February 16, 2026